title: Hand-foot syndrome following decitabine.
authors.affiliation: Division of Hospital Medicine, Washington University School of Medicine, St. Louis, USA.
authors.forename: Alaa M
authors.initials: AM
authors.lastname: Ali
authors.affiliation: Division of Oncology, Stem Cell Biology Section, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8007, St. Louis, MO, 63110, USA.
authors.forename: Meagan
authors.initials: M
authors.lastname: Jacoby
authors.affiliation: Division of Oncology, Stem Cell Biology Section, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8007, St. Louis, MO, 63110, USA. jwelch@dom.wustl.edu.
authors.forename: John S
authors.initials: JS
authors.lastname: Welch
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077209:Decitabine; D060831:Hand-Foot Syndrome / Q000175:diagnosis*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine